| Application no. and date | 16710891.9 (espacenet) (Federated) (European Patent Register), 20160303 | | Patent/reg. no. and date | DK/EP 3265122, 20220504 | | Publication date | 20180110 | | Priority no. and date | US 201562128373 P, 20150304, US 201562264068 P, 20151207 | | EP pub. no. and date |
EP 3265122 20180110 | | Effective date | | | Applicant/owner | Eisai R&D Management Co., Ltd., 6-10, Koishikawa 4-chome
Bunkyo-ku
Tokyo 112-8088, JP,
Merck Sharp & Dohme Corp., 126 East Lincoln Avenue
Rahway, NJ 07065, US | | Applicant ref. no. | | | Inventor | MATSUI, Junji, c/o Eisai Co., Ltd.
1-3 Tokodai
5-Chome
Tsukuba-shi
Ibaraki 300-2635, JP,
AKTAN, Gursel, 351 North Sumneytown Pike
North Wales, PA 19454, US,
KARANTZA, Vassiliki, 126 E. Lincoln Avenue
Rahway, NJ 07065, US,
YUAN, RuiRong, 4 Horizon Rd. Apt. 620
Fort Lee, NJ 07024, US,
FUNAHASHI, Yasuhiro, c/o Eisai Co., Ltd.
1-3 Tokodai
5-Chome
Tsukuba-shi, Ibaraki 300-2635, JP,
BERRAK, Erhan, 217 Sunrise Court
River Vale, NJ 07675, US | | Representative | | | Opponent | | | IPC Class | A61K 31/357 (2006.01) , A61K 39/395 (2006.01) , A61K 45/06 (2006.01) , A61K 47/26 (2006.01) , A61P 35/00 (2006.01) , A61P 35/04 (2006.01) | | Title | COMBINATION OF A PD-1 ANTAGONIST AND ERIBULIN FOR TREATING CANCER | | Int. application no. | US2016020734 | | Int. publication no. | WO2016141209 | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
